TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H100. A total of 27 filers reported holding TRACON PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $62,000 | -58.4% | 98,259 | +35.0% | 0.00% | -50.0% |
| Q3 2018 | $149,000 | -32.9% | 72,795 | -11.4% | 0.00% | -33.3% |
| Q2 2018 | $222,000 | -36.2% | 82,191 | -45.7% | 0.00% | -50.0% |
| Q1 2018 | $348,000 | +19.6% | 151,499 | +74.4% | 0.01% | +20.0% |
| Q4 2017 | $291,000 | +134.7% | 86,872 | +68.4% | 0.01% | +66.7% |
| Q2 2017 | $124,000 | +87.9% | 51,580 | +194.7% | 0.00% | +200.0% |
| Q1 2017 | $66,000 | -53.2% | 17,500 | -39.0% | 0.00% | -66.7% |
| Q4 2016 | $141,000 | -41.2% | 28,700 | -20.3% | 0.00% | -25.0% |
| Q3 2016 | $240,000 | +48.1% | 36,000 | -3.0% | 0.00% | +33.3% |
| Q2 2016 | $162,000 | – | 37,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 683 Capital Management, LLC | 995,000 | $3,134,000 | 0.33% |
| NEA Management Company, LLC | 2,759,217 | $8,692,000 | 0.30% |
| Eventide Asset Management | 900,000 | $2,835,000 | 0.16% |
| QVT Financial LP | 308,227 | $916,000 | 0.03% |
| Candriam S.C.A. | 143,000 | $450,000 | 0.01% |
| Virtu Financial LLC | 23,684 | $75,000 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 13,352 | $42,000 | 0.00% |
| BLUESTEIN R H & CO LLC | 16,000 | $50,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 54,135 | $171,000 | 0.00% |
| Alyeska Investment Group, L.P. | 97,676 | $308,000 | 0.00% |